Literature DB >> 3986072

Neurological toxicity of the subarachnoid infusion of bupivacaine, lignocaine or 2-chloroprocaine in the rat.

D F Li, M Bahar, G Cole, M Rosen.   

Abstract

Neurotoxicity after subarachnoid infusion of bupivacaine, lignocaine and 2-chloroprocaine was studied in a chronic rat model. Hartmann's solution 100 microliter h-1 was infused as a control, and 0.5% bupivacaine, 1.5% lignocaine and 2.0% 2-chloroprocaine were infused at 100 microliter h-1 for 3, 6 or 24 h, to five rats in each group. No residual paralysis occurred in the control group, but 27 of 45 rats (60%) which received an infusion of local anaesthetic had residual paralysis lasting until sacrifice at 7 days. The incidence of paralysis was dependent on the duration of exposure to the local anaesthetic, but there were no significant differences in incidence between any of the local anaesthetics tested. Abnormal histology, in the form of neuronal vacuolation, was not a sensitive index, being present in control rats, but more intense in those receiving lignocaine and 2-chloroprocaine than in those given bupivacaine; no correlation with clinical findings could be established. The neurotoxic effects of each local anaesthetic tested as a continuous intrathecal infusion were dose related in the rat, which may be a useful model for screening other local anaesthetics.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3986072     DOI: 10.1093/bja/57.4.424

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  8 in total

1.  Differential effects of peripheral versus central coadministration of QX-314 and capsaicin on neuropathic pain in rats.

Authors:  Jun Shen; Lyle E Fox; Jianguo Cheng
Journal:  Anesthesiology       Date:  2012-08       Impact factor: 7.892

2.  Pathology of local anesthetic-induced nerve injury.

Authors:  M W Kalichman; H C Powell; R R Myers
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 3.  Pathophysiology of peripheral nerve injury during regional anesthesia.

Authors:  Quinn H Hogan
Journal:  Reg Anesth Pain Med       Date:  2008 Sep-Oct       Impact factor: 6.288

4.  Persistent sacral nerve root deficits after continuous spinal anaesthesia.

Authors:  R M Schell; F S Brauer; D J Cole; R L Applegate
Journal:  Can J Anaesth       Date:  1991-10       Impact factor: 5.063

5.  Neuropathic pain: early spontaneous afferent activity is the trigger.

Authors:  Wenrui Xie; Judith A Strong; Johanna T A Meij; Jun-Ming Zhang; Lei Yu
Journal:  Pain       Date:  2005-08       Impact factor: 7.926

Review 6.  Intrathecal Drug Delivery: Advances and Applications in the Management of Chronic Pain Patient.

Authors:  Jose De Andres; Salim Hayek; Christophe Perruchoud; Melinda M Lawrence; Miguel Angel Reina; Carmen De Andres-Serrano; Ruben Rubio-Haro; Mathew Hunt; Tony L Yaksh
Journal:  Front Pain Res (Lausanne)       Date:  2022-06-16

7.  Intrathecal bupivacaine for head and neck pain.

Authors:  Shawn A Belverud; Alon Y Mogilner; Michael Schulder
Journal:  Local Reg Anesth       Date:  2010-10-11

8.  Transient neurological symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics in adult surgical patients: a network meta-analysis.

Authors:  Patrice Forget; Josip A Borovac; Elizabeth M Thackeray; Nathan L Pace
Journal:  Cochrane Database Syst Rev       Date:  2019-12-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.